Jacob Ph.d Vanlandingham - 19 May 2022 Form 4 Insider Report for Odyssey Health, Inc. (ODYY)

Role: VP of Drug Development
Signature: /s/ Christine M. Farrell, Attorney-in-Fact for Jacob Vanlandingham
Issuer symbol: ODYY
Transactions as of: 19 May 2022
Net transactions value: +$30,000
Form type: 4
Filing time: 08 Jun 2022, 17:18:31 UTC
Next filing: 14 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ODYY	Stock Option (Right to Buy)	Award	$30,000	+100,000	+10%	$0.3000	1,100,000	19 May 2022	Common Stock	100,000	$0.3000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Vesting Schedule: 50% vest on first dosed subject of Phase 2 Trial; 50% on last dosed subject of Phase 2 Trial.